Key result
Cesium chloride ingestion triggers torsades de pointes and recurrent syncope.
Why the study?
Up to 50 percent of patients with cancer use alternative medicine that may include cesium chloride, an inward-rectifying potassium-channel blocker used in animal models of long-QT syndrome and torsades de pointes.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Case report reveals recurrent syncope and torsades de pointes after alternative cesium therapy, highlighting cardiotoxicity risks.
To the Editor: Up to 50 percent of patients with cancer seek help in the form of alternative medicine.1 Such therapies may include cesium chloride, a blocker of the inward-rectifying potassium channel that is used in animal models to study the long-QT syndrome and torsades de pointes.2 We report a documented case of cesium-induced toxicity. A 62-year-old man presented with recurrent syncope. The patient had no history of cardiovascular disease, syncope, or palpitations and no family history of sudden death. Previously, the patient had had normal echocardiographic and laboratory data. The patient underwent a naturopathic treatment consisting of 2000 mg . . .
No takes yet. Share an insight, caveat, or question.
Pintér et al. (2002) conducted a case report in Cesium-induced torsades de pointes and recurrent syncope (n=1). Cesium chloride was evaluated on Torsades de pointes and recurrent syncope. Naturopathic treatment with 2000 mg of cesium chloride induced torsades de pointes and recurrent syncope in a 62-year-old man.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: